Related Experiment Video
Updated: Feb 27, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Asymptomatic Lower Extremity Deep Vein Thrombosis - Clinical Characteristics, Management Strategies, and Long-Term
Yugo Yamashita1, Hiroki Shiomi1, Takeshi Morimoto2
1Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.
Insights
The prognosis for asymptomatic deep vein thrombosis (DVT) is unclear. While anticoagulants increase bleeding risk, they may benefit patients with active cancer by reducing recurrent venous thromboembolism (VTE).
Area of Science:
- Vascular Medicine
- Hematology
- Oncology
Background:
- The prognosis and optimal management of asymptomatic deep vein thrombosis (DVT) remain uncertain, lacking established guidelines for detection and treatment.
- Asymptomatic DVT affects patient outcomes, necessitating further research into its long-term implications and therapeutic strategies.
Purpose of the Study:
- To evaluate the long-term outcomes of patients diagnosed with asymptomatic lower extremity deep vein thrombosis (DVT).
- To assess the efficacy and safety of prolonged anticoagulant therapy in this patient cohort, particularly in subgroups with active cancer.
Main Methods:
- A retrospective analysis of 300 patients with asymptomatic lower extremity DVT diagnosed via ultrasound between January 2010 and September 2015.
- Data collected included patient demographics, cancer status, DVT characteristics (unprovoked/distal), treatment duration, and outcomes such as symptomatic recurrent venous thromboembolism (VTE), major bleeding, and all-cause mortality.
Main Results:
- The 5-year cumulative incidence of symptomatic recurrent VTE was 14.5%, major bleeding was 16.6%, and all-cause death was 34.1%.
- Prolonged anticoagulant therapy, used in 77% of patients, was associated with a significantly higher risk of major bleeding (20.5% vs. 1.5%) but did not significantly affect VTE incidence.
- In patients with active cancer, anticoagulant therapy showed a significant benefit in reducing the risk of VTE (HR, 0.22; 95% CI: 0.05-0.95).
Conclusions:
- Prolonged anticoagulant therapy in asymptomatic DVT patients increases major bleeding risk, with discontinuation common within a year.
- Subgroup analysis suggests a potential benefit of prolonged anticoagulation in patients with active cancer, reducing the rate of symptomatic recurrent VTE.
Background:
The prognosis of asymptomatic deep vein thrombosis (DVT) is uncertain and there is no consensus on the necessity of detection and treatment.
Methods And Results:
We retrospectively evaluated 300 patients with asymptomatic lower extremity DVT screened from 4,514 consecutive patients on ultrasound at Kyoto University Hospital between January 2010 and September 2015. The subjects had concomitant active cancer in 40%, unprovoked DVT in 59%, and distal DVT in 70%. The cumulative 5-year incidences of symptomatic recurrent venous thromboembolism (VTE); major bleeding; and all-cause death were 14.5%, 16.6%, and 34.1%, respectively. Among 232 patients (77%) with prolonged anticoagulant therapy, anticoagulants were discontinued in 48.4% at 1 year. Anticoagulant therapy was associated with a significantly higher incidence of major bleeding compared with the non-anticoagulant group (20.5% vs. 1.5%, P=0.01) with no significant effect on the incidence of VTE. In patients with active cancer, the favorable effect of anticoagulants relative to no anticoagulants for VTE was significant (HR, 0.22; 95% CI: 0.05-0.95).
Conclusions:
Prolonged anticoagulants therapy was implemented in the majority of patients with asymptomatic DVT, but was associated with a significantly higher risk for major bleeding. On subgroup analysis in patients with active cancer, however, there appeared to be a benefit of prolonged anticoagulant therapy in decreasing the rate of symptomatic recurrent VTE.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management

